The global obesity treatment market size is expected to reach USD 27.10 billion by 2028 at a CAGR of 15.7%, according to a new report by Reports and Data. One of the key parameters driving market revenue growth is rising prevalence of obesity due to sedentary lifestyles, unhealthy eating habits, and lack of physical activity. The global market growth is further bolstered by increasing commercial availability of weight-management programs, rising demand for technologically enhanced weight-loss devices and equipment, and rise in government initiatives undertaken to promote awareness about obesity and its adverse health outcomes. Furthermore, growing trends of health and fitness such as gym culture, increasing cosmetic concerns, especially among millennials, increasing inclination towards weight-loss surgeries, and rising healthcare expenditure create market growth opportunities.
Obesity is a medical condition caused by growing size of fat cells in the body. This condition is associated with various health problems including diabetes, cardiovascular disease, high blood pressure and several types of cancer. Some of the major causes of obesity include lack of sleep, physical inactiveness, and excessive consumption of junk food. It is considered that the mainstay of obesity treatment is changes in lifestyle such as adequate diet and physical fitness. Dietary changes, improved physical activity, and behavioral changes are proven to help improve the condition and prevent various obesity-related health issues. In more serious cases, specific weight-loss procedures and medications are prescribed by physicians. Some commonly known FDA-approved weight-loss drugs are orlistat (Xenical, Alli), naltrexone-bupropion (Contrave), phentermine-topiramate (Qsymia), semaglutide (Wegovy), and liraglutide (Saxenda).
Top Companies Profiled in the Report Include:
Medtronic, Ethicon (subsidiary of Johnson Johnson), Cousin Biotech, EnteroMedics, Inc., and USGI Medical, Inc. VIVUS, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Allergan Plc
Obesity Treatments Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Major Highlights of the Obesity Treatments Market Report:
- Based on surgery type, the Biliopancreatic Diversion with Duodenal Switch (BPD/DS) segment is the leading segment, with the highest revenue share in the global obesity treatment market in 2020. Increasing prevalence of obesity-related health issues such as high blood pressure, type 2 diabetes, and other medical problems and growing preference for surgical procedures are expected to bolster this segment’s growth in the coming years.
- Based on drug type, the combination drugs segment reached the largest market share in 2020. Surging prevalence of obesity worldwide and introduction of effective combination therapies for weight management fuel this segment’s growth.
- North America accounted for the largest revenue share of 53% in the global obesity treatment market in 2020. Easy availability of minimally invasive procedures, increasing investments in technological innovations, and rise in research development activities are the key factors driving the North America market growth. The Asia Pacific market is expected to register the highest CAGR of 18% during the forecast period. Growing awareness about the unfavorable health impacts of obesity, advancing healthcare infrastructure, and growing medical tourism are projected to boost market growth in this region.
- The leading players in the global obesity treatment market include Medtronic, Ethicon (subsidiary of Johnson Johnson), Cousin Biotech, EnteroMedics, Inc., and USGI Medical, Inc. VIVUS, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, and Allergan Plc.
Additionally, the report consists a detailed analysis of the segmentation of the Obesity Treatments Market based on product types and end-use/application offered in the Obesity Treatments Market -
Surgery Type Outlook (Revenue, USD Billion; 2020-2028)
- Biliopancreatic diversion with Duodenal Switch (BPD/DS)
- Adjusting gastric Banding
- Roux-en-Y Gastric Bypass
- Sleeve gastrectomy
- Endoscopic Procedures
Drug Type Outlook (Revenue, USD Billion; 2020-2028)
- Appetite suppressants
- Combination drugs
- Malabsorption
- Satiety drugs
End-use (Revenue, USD Billion; 2020-2028)
- Clinics
- Hospitals
- Beauty institutions
- Others
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Request for Customization this report - https://www.reportsanddata.com/request-customization-form/1480
